LindaMarie SmiResarMD

PubMed

• 18 citations
  Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide
  William J. Savage, Patricia A. DeRusso, Linda M.S. Resar, Allen R. Chen, Meghan A. Higman
  Pediatric Blood & Cancer. 2007-12-01
• 84 citations
  The high-mobility group A1a/signal transducer and activator of transcription-3 axis: An achilles heel for hematopoietic malignancies?
  Joelle Hillion, Surajit Dhara, Takita Felder Sumter, Mita Mukherjee, Francescopaolo Di Cello
  Cancer Research. 2008-12-15
• 11 citations
  Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.
  Michael Williams, Lingling Xian, Tait Huso, Jeong-Jin Park, David L. Huso
  Journal of Proteome Research. 2016-11-04

Abstracts/Posters

• High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN
  Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational Burden
  Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL
  Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Use of Pegylated Interferon in Six Pediatric Patients with Myeloproliferative Neoplasms
  Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models
  Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all